[ Price : $8.95]
FDA seeks public input on ways to expand drug repurposing efforts, aiming to accelerate treatment options for patients with unmet ...[ Price : $8.95]
FDA issues updated guidance for companies developing therapies to treat, prevent or reduce recurrence of Clostridioides difficile ...[ Price : $8.95]
FDA releases a new guidance outlining how drugmakers should design and conduct postapproval studies evaluating the safety of drugs...[ Price : $8.95]
FDA posts new technical guidance document outlining how sponsors should submit continuous glucose monitoring data collected during...[ Price : $8.95]
Boston Scientific begins a Class 1 recall (device correction) involving certain pacemakers and cardiac resynchronization therapy p...[ Price : $8.95]
Several media outlets report that President Trump has signed off on a plan to remove FDA commissioner Marty Makary from his post.[ Price : $8.95]
FDA approves a Partner Therapeutics BLA for Bizengri (zenocutuzumab-zbco) for adults with advanced, unresectable or metastatic cho...[ Price : $8.95]
Atara Biotherapeutics says it and partner Pierre Fabre Pharmaceuticals have received feedback from FDA outlining a potential path ...